LON:RB - Reckitt Benckiser Group Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 6,413 -3.00 (-0.05 %) (As of 05/24/2019 04:00 PM ET)Previous CloseGBX 6,413Today's RangeGBX 6,382 - GBX 6,44852-Week RangeGBX 5,559 - GBX 7,174Volume1.27 million shsAverage Volume1.72 million shsMarket Capitalization£45.40 billionP/E Ratio21.04Dividend Yield3.23%BetaN/A ProfileAnalyst RatingsChartDividendInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; footcare and footwear products; sore throat medications; and women's beauty products under the Nurofen, Scholl, Strepsils, and Veet brand. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet bowl cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; and fabric washing products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as infant and child nutrition products under the Enfamil and Nutramigen brands. It operates in the United States, Canada, Europe, Russia/CIS, Turkey, Israel, Australia, New Zealand, and internationally. The company was founded in 1823 and is headquartered in Slough, the United Kingdom. Receive RB News and Ratings via Email Sign-up to receive the latest news and ratings for RB and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Personal Products Sub-IndustryN/A SectorConsumer Goods Current SymbolLON:RB Previous Symbol CUSIPN/A CIKN/A Webhttp://www.rb.com/ Phone+44-1753-217800Debt Debt-to-Equity Ratio80.49 Current Ratio0.65 Quick Ratio0.47Price-To-Earnings Trailing P/E Ratio21.04 Forward P/E Ratio0.18 P/E GrowthN/A Sales & Book Value Annual Sales£12.60 billion Price / Sales3.60 Cash FlowGBX 215.79 per share Price / Cash Flow29.72 Book ValueGBX 2,083.70 per share Price / Book3.08Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees37,345 Outstanding Shares707,944,000Market Cap£45.40 billion Next Earnings Date7/30/2019 (Estimated) OptionableNot Optionable Reckitt Benckiser Group (LON:RB) Frequently Asked Questions What is Reckitt Benckiser Group's stock symbol? Reckitt Benckiser Group trades on the London Stock Exchange (LON) under the ticker symbol "RB." How often does Reckitt Benckiser Group pay dividends? What is the dividend yield for Reckitt Benckiser Group? Reckitt Benckiser Group declared a dividend on Monday, February 18th. Shareholders of record on Thursday, April 18th will be paid a dividend of GBX 100.20 per share on Thursday, May 23rd. This represents a yield of 1.67%. The ex-dividend date of this dividend is Thursday, April 18th. This is a boost from Reckitt Benckiser Group's previous dividend of $70.50. The official announcement can be accessed at this link. View Reckitt Benckiser Group's Dividend History. When is Reckitt Benckiser Group's next earnings date? Reckitt Benckiser Group is scheduled to release their next quarterly earnings announcement on Tuesday, July 30th 2019. View Earnings Estimates for Reckitt Benckiser Group. What price target have analysts set for RB? 19 analysts have issued 12-month price targets for Reckitt Benckiser Group's shares. Their predictions range from GBX 5,300 to GBX 9,000. On average, they expect Reckitt Benckiser Group's stock price to reach GBX 7,117.78 in the next twelve months. This suggests a possible upside of 11.0% from the stock's current price. View Analyst Price Targets for Reckitt Benckiser Group. What is the consensus analysts' recommendation for Reckitt Benckiser Group? 19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Reckitt Benckiser Group in the last year. There are currently 3 sell ratings, 4 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Reckitt Benckiser Group. Has Reckitt Benckiser Group been receiving favorable news coverage? News articles about RB stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Reckitt Benckiser Group earned a coverage optimism score of 1.4 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the immediate future. Who are some of Reckitt Benckiser Group's key competitors? Some companies that are related to Reckitt Benckiser Group include Blackmores (BKL), Churchill China (CHH), McBride (MCB), KP Tissue (KPT), Swallowfield (SWL), Creightons (CRL), CCA Industries (CAW), Byotrol (BYOT), Provexis (PXS), Scott's Liquid Gold (SLGD) and Unibail Rodamco (UL). What other stocks do shareholders of Reckitt Benckiser Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Reckitt Benckiser Group investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Athabasca Oil (ATH), Chipotle Mexican Grill (CMG), NIC (EGOV), Aegean Marine Petroleum Network (ANW), Centrica (CNA), Prudential (PRU) and ALJ Regional (ALJJ). Who are Reckitt Benckiser Group's key executives? Reckitt Benckiser Group's management team includes the folowing people: Mr. Rakesh Kapoor, CEO & Exec. Director (Age 60)Mr. Adrian Nevil Hennah, CFO & Exec. Director (Age 62)Mr. Seth Cohen, Chief Information OfficerMr. Richard Joyce, Sr. VP of Investor RelationsMr. Rupert Bondy, Sr. VP, Gen. Counsel & Company Sec. (Age 57) How do I buy shares of Reckitt Benckiser Group? Shares of RB and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Reckitt Benckiser Group's stock price today? One share of RB stock can currently be purchased for approximately GBX 6,413. How big of a company is Reckitt Benckiser Group? Reckitt Benckiser Group has a market capitalization of £45.40 billion and generates £12.60 billion in revenue each year. Reckitt Benckiser Group employs 37,345 workers across the globe. What is Reckitt Benckiser Group's official website? The official website for Reckitt Benckiser Group is http://www.rb.com/. How can I contact Reckitt Benckiser Group? Reckitt Benckiser Group's mailing address is 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom. The company can be reached via phone at +44-1753-217800. MarketBeat Community Rating for Reckitt Benckiser Group (LON RB)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 1,180 (Vote Outperform)Underperform Votes: 990 (Vote Underperform)Total Votes: 2,170MarketBeat's community ratings are surveys of what our community members think about Reckitt Benckiser Group and other stocks. Vote "Outperform" if you believe RB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RB will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/25/2019 by MarketBeat.com StaffFeatured Article: Buy-Side Analysts Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.